What is the best biomarker to predict acute kidney injury during living donor renal transplantation, a single center experience.

What is the best biomarker to predict acute kidney injury during living donor renal transplantation, a single center experience. - The best biomarker during renal transplantation.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014282

Enrollment

Registered

2014-06-16

Start date

2012-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

living donor renal transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with written informed consent(or by next of kin)

Exclusion criteria

Exclusion criteria: Patients without written informed consent(or by next of kin)

Design outcomes

Primary

Measure	Time frame
The concentrations of biomarkers during living donor renal transplantation . The measured biomarkers were included urinary L-FABP(liver-type fatty acid binding protein), urinary H-FABP(heart-type fatty acid binding protein), urinary NGAL(neutrophil gelatinase-associated lipocalin), urinary Lf(lactoferrin) and plasma IL-18(interleukin 18).	—

Countries

Japan

Contacts

Public ContactRikizo Kogawa

Toho University School of Medicine Department of Anesthesiology

rikizo.kogawa@med.toho-u.ac.jp03-3762-4151

Outcome results